Felisa Reyes-Ortega Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences Monash University Biography Publications Institution JoVE Articles Felisa Reyes-Ortega has not added a biography. If you are Felisa Reyes-Ortega and would like to personalize this page please email our Author Liaison for assistance. Publications Antibiotic-non-antibiotic Combinations for Combating Extremely Drug-resistant Gram-negative 'superbugs' Essays in Biochemistry. Feb, 2017 | Pubmed ID: 28258235 From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators Microbial Drug Resistance (Larchmont, N.Y.). Jul, 2017 | Pubmed ID: 27935770 Development of HPLC and LC-MS/MS Methods for the Analysis of Ivacaftor, Its Major Metabolites and Lumacaftor in Plasma and Sputum of Cystic Fibrosis Patients Treated with ORKAMBI or KALYDECO Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. Dec, 2016 | Pubmed ID: 27792891 Chitosan-tripolyphosphate Nanoparticles As Arrabidaea Chica Standardized Extract Carrier: Synthesis, Characterization, Biocompatibility, and Antiulcerogenic Activity International Journal of Nanomedicine. 2015 | Pubmed ID: 26089666 Bioactive Bilayered Dressing for Compromised Epidermal Tissue Regeneration with Sequential Activity of Complementary Agents Acta Biomaterialia. Sep, 2015 | Pubmed ID: 26022967 Thermosensitive Macroporous Cryogels Functionalized with Bioactive Chitosan/bemiparin Nanoparticles Macromolecular Bioscience. Nov, 2013 | Pubmed ID: 23956200 שיטת אופטימיזציה LC-MS/MS לניתוח תפוקה גבוהה של דגימות קליניות של Ivacaftor, שלה מטבוליטים העיקריים Lumacaftor של נוזלים ביולוגיים של חולי סיסטיק פיברוזיס Elena K. Schneider1, Felisa Reyes-Ortega1, Jian Li1,2, Tony Velkov1 1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 2Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University JoVE 56084 Medicine
שיטת אופטימיזציה LC-MS/MS לניתוח תפוקה גבוהה של דגימות קליניות של Ivacaftor, שלה מטבוליטים העיקריים Lumacaftor של נוזלים ביולוגיים של חולי סיסטיק פיברוזיס Elena K. Schneider1, Felisa Reyes-Ortega1, Jian Li1,2, Tony Velkov1 1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 2Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University JoVE 56084 Medicine
